ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here? [Anatol J Cardiol]
Anatol J Cardiol. 2020; 24(1): 19-20 | DOI: 10.14744/AnatolJCardiol.2020.73232

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

Imdat Eroğlu1, Burcu Çelik Eroğlu1, Oğuz Abdullah Uyaroğlu2, Gülay Sain Güven2
1Department of Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey
2Department of General Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey

Keywords: COVID-19, Angiotensin receptor blockers, Angiotensin Enzyme Inhibitors, Statins, Heparin
Imdat Eroğlu, Burcu Çelik Eroğlu, Oğuz Abdullah Uyaroğlu, Gülay Sain Güven. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?. Anatol J Cardiol. 2020; 24(1): 19-20

Corresponding Author: Oğuz Abdullah Uyaroğlu, Türkiye
Manuscript Language: English
TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search



  1. Home
  2. About
  3. Abstrating and Indexing
  1. Copyright
  2. Aim and Scope
  3. Editorial Board
  1. Instructions for Authors
  2. ICMJE Recommendations
  3. Contact

Copyright © 2023 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media. 
LookUs  &   Online Makale